Basic information Safety Supplier Related

N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide

Basic information Safety Supplier Related

N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide Basic information

Product Name:
N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide
Synonyms:
  • N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide
  • N-(4-Aminophenyl)-N,4-dimethyl-1-piperazineacetamide
  • N-[(4-methyl-piperazin-1-yl)methylcarbonyl]-N-methyl-p-phenylendiamine
  • -N-methyl-2-(4-methylpiperazin-1-yl)
  • Nintedanib Intermediate 2
  • N-(4-aminophenyl)-N-4-dimethyl-1-peperazineacetamide
  • N-(4-Aminophenyl)-N-methyl-2-(4-methyl-1-piperazinyl)acetamide
  • 1-Piperazineacetamide, N-(4-aminophenyl)-N,4-dimethyl-
CAS:
262368-30-9
MF:
C14H22N4O
MW:
262.35
EINECS:
939-634-6
Product Categories:
  • Intermediate of BIBF-1120 and PKI587
  • 262368-30-9
Mol File:
262368-30-9.mol
More
Less

N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide Chemical Properties

Melting point:
152 - 154°C
Boiling point:
434.8±40.0 °C(Predicted)
Density 
1.151
storage temp. 
Keep in dark place,Inert atmosphere,Room temperature
solubility 
DMSO (Slightly), Methanol (Slightly)
form 
Solid
pka
7.43±0.10(Predicted)
color 
Off-White to Pale Beige
InChI
InChI=1S/C14H22N4O/c1-16-7-9-18(10-8-16)11-14(19)17(2)13-5-3-12(15)4-6-13/h3-6H,7-11,15H2,1-2H3
InChIKey
LBWNQLVDYPNHAV-UHFFFAOYSA-N
SMILES
N1(CC(N(C2=CC=C(N)C=C2)C)=O)CCN(C)CC1
More
Less

Safety Information

HS Code 
2933998090
More
Less

N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide Usage And Synthesis

Uses

N-(4-Aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide acts as a reagent for the preparation, angiokinase inhibitory, antitumor activity and pharmacokinectic properties of deuterated derivatives of nintedanib.

Synthesis

109-01-3

2653-16-9

262368-30-9

GENERAL STEPS: 2-Chloro-N-methyl-N-(4-nitrophenyl)acetamide (210.0 g, 0.9185 mol) was suspended in toluene (1157.56 mL) and heated to 40 °C. The mixture was then purified by aqueous solution of N-methylpiperazine (252.65 mL, 2.48 eq.). N-methylpiperazine (252.65 mL, 2.48 eq.) was added dropwise over 30 min. The reaction mixture was stirred at 55 °C for 2 hours. After cooling to room temperature, the reaction mixture was washed with water (157.23 mL) and the organic layer was diluted with isopropanol (1075.33 mL). Palladium/carbon catalyst (18.81 g) was added and hydrogenated overnight at 20 °C under 1 bar hydrogen pressure. After the reaction was complete, the catalyst was removed by filtration and the filtrate was concentrated to about 150 mL and ground with ether (120.0 mL). The crystalline product was collected by filtration, washed with ether and dried under vacuum to afford N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide 170 g (70.5% yield).

References

[1] Patent: WO2012/68441, 2012, A2. Location in patent: Page/Page column 13; 14

N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamideSupplier

Jinan XuanDe Chemical Co., Ltd. Gold
Tel
0531-88803958 18866891188
Email
18853169188@163.com
Chengdu D-innovation Pharmaceutical Co.,LTD Gold
Tel
028-85105512 17802830247
Email
baozuqiang@d-innovation.com
Nanjing CoreTech Biomedical Co,.Ltd Gold
Tel
025-52880806 13770327895
Email
API@core-tech.com.cn
CHANGZHOU GARDE PHARMTECH CO.,LTD Gold
Tel
18006124028
Email
gardepharm@163.com
BeiJing Hwrk Chemicals Limted
Tel
0757-86329057 18934348241
Email
sales4.gd@hwrkchemical.com